Literature DB >> 22588403

Treatment of femoral neck fractures with bipolar hemiarthroplasty using a modified minimally invasive posterior approach in patients with neurological disorders.

Suk-Ku Han1, Yong-Sik Kim, Soo-Hwan Kang.   

Abstract

Bipolar hemiarthroplasty is a useful treatment for displaced femoral neck fractures in elderly patients. Although uncommon, dislocation is problematic, particularly in older patients, and those with neurologic disorders are at an increased risk for this complication. Recently, a modified posterior approach to the hip intended to enhance hip joint stability by preserving the short external rotators was described. Therefore, the dislocation rate was compared after bipolar hemiarthroplasty using the modified or standard minimally invasive posterior approach.A retrospective analysis was performed of 67 patients older than 65 years with displaced femoral neck fractures and neurological disorders who underwent bipolar hemiarthroplasty using the modified and standard approaches in 28 and 39 hips, respectively. Follow-up averaged 19.3 months. Dislocation rates for the treatment and control groups were 0% and 7.7%, respectively (P<.01). No significant difference existed in postoperative bleeding, operative time, or length of hospital stay between groups. These data suggest a lower dislocation rate after bipolar hemiarthroplasty via the modified, short external rotator-sparing approach for treating displaced femoral neck fractures in elderly patients with neurological disorders. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2012        PMID: 22588403     DOI: 10.3928/01477447-20120426-15

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  8 in total

1.  What Are the Risk Factors for Dislocation of Hip Bipolar Hemiarthroplasty Through the Anterolateral Approach? A Nested Case-control Study.

Authors:  Lianhua Li; Jixin Ren; Jia Liu; Hao Wang; Qinghua Sang; Zhi Liu; Tiansheng Sun
Journal:  Clin Orthop Relat Res       Date:  2016-08-30       Impact factor: 4.176

2.  Comparison of supercapsular percutaneously assisted approach total hip versus conventional posterior approach for total hip arthroplasty: a prospective, randomized controlled trial.

Authors:  Jun Xie; Hongxi Zhang; Lei Wang; Xiang Yao; Zhanpeng Pan; Qinyi Jiang
Journal:  J Orthop Surg Res       Date:  2017-09-25       Impact factor: 2.359

3.  Use of the supercapsular percutaneously assisted total hip approach for femoral neck fractures: surgical technique and case series.

Authors:  Andrew W Bodrogi; Robert Sciortino; David A Fitch; Wade Gofton
Journal:  J Orthop Surg Res       Date:  2016-10-12       Impact factor: 2.359

4.  Hip Hemiarthroplasty in Neurologic or Cognitively Impaired Patients: A Case Series of Post-operative Dislocations.

Authors:  Robert Pearse Piggott; Emmett Karl Smithwick; Colin Gerard Murphy
Journal:  J Orthop Case Rep       Date:  2018 Jan-Feb

Review 5.  A scoping review comparing two common surgical approaches to the hip for hemiarthroplasty.

Authors:  James Fullam; Paraskevas G Theodosi; John Charity; Victoria A Goodwin
Journal:  BMC Surg       Date:  2019-03-08       Impact factor: 2.102

6.  Early results of displaced femoral neck fragility fractures treated with supercapsular percutaneous-assisted total hip arthroplasty.

Authors:  Ronald J Mitchell; Andrew B Kay; Kevin M Smith; Stephen B Murphy; Daniel T Le
Journal:  Arthroplast Today       Date:  2019-03-16

Review 7.  The role of superior capsular approach (SuperPATH) in the treatment of femoral neck fractures with hemiarthroplasty implantation: our experience and review of literature.

Authors:  Michelangelo Scaglione; Francesco Casella; Michele Giuntoli; Fabio Celli; Luca Fabbri; Stefano Marchetti
Journal:  Acta Biomed       Date:  2020-11-11

8.  A Systematic Review and Meta-Analysis of the SuperPATH Approach in Hip Arthroplasty.

Authors:  Yanzhi Ge; Zuxiang Chen; Qisong Chen; Yanbin Fu; Mengqiang Fan; Ting Li; Letian Shan; Peijian Tong; Li Zhou
Journal:  Biomed Res Int       Date:  2021-07-21       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.